{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:21Z","timestamp":1786119261210,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>\n                    Here, we present a precision oncologic approach for localized prostate cancer (PCa) in a 66-year-old man. Overcoming the limitations of conventional MRI in delineating tumor extent and multifocality, preoperative\n                    <jats:sup>68<\/jats:sup>\n                    Ga-PSMA PET\/MRI precisely defined the index lesion and excluded metastases. This diagnostic workflow was directly translated into therapy through PET\/MRI-US fusion-guided irreversible electroporation (IRE). The procedure targeted the tumor accurately while sparing surrounding functional anatomy. Significant PSA and phi decline post-IRE confirmed therapeutic efficacy. This case demonstrates that integrating molecularly targeted diagnostics with advanced image-guided focal therapy enables maximal precision in oncologic control.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006484","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:00:08Z","timestamp":1777039208000},"page":"661-663","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["PSMA PET\/MRI-US Fusion-Guided Irreversible Electroporation for Focal Therapy of Prostate Cancer"],"prefix":"10.1097","volume":"51","author":[{"given":"Qi-Dong","family":"Xia","sequence":"first","affiliation":[{"name":"Department of Urology, Tongji Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yao","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hua","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, Tongji Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Gang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Tongji Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"R1-20260702","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s00259-019-04438-w","article-title":"Comparison of PSMA-ligand PET\/CT and multiparametric MRI for the detection of recurrent prostate cancer in the pelvis","volume":"46","author":"Afshar-Oromieh","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1148\/radiol.2019190687","article-title":"Diagnostic accuracy of multiparametric MRI versus (68)Ga-PSMA-11 PET\/MRI for extracapsular extension and seminal vesicle invasion in patients with prostate cancer","volume":"293","author":"Muehlematter","year":"2019","journal-title":"Radiology"},{"key":"R3-20260702","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11604-024-01646-9","article-title":"PSMA PET\/CT imaging and its application to prostate cancer treatment","volume":"43","author":"Otani","year":"2025","journal-title":"Jpn J Radiol"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2967\/jnumed.120.257238","article-title":"Current and emerging clinical applications of PSMA PET diagnostic imaging for prostate cancer","volume":"62","author":"Farolfi","year":"2021","journal-title":"J Nucl Med"},{"key":"R5-20260702","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.diii.2022.09.009","article-title":"Irreversible electroporation and electrochemotherapy in oncology: state of the art","volume":"103","author":"Tasu","year":"2022","journal-title":"Diagn Interv Imaging"},{"key":"R6-20260702","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/bju.16720","article-title":"The diagnostic value of MRI for persistent prostate cancer following irreversible electroporation focal therapy","volume":"136","author":"Zhang","year":"2025","journal-title":"BJU Int"},{"key":"R7-20260702","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1007\/s00330-015-4042-3","article-title":"MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy","volume":"26","author":"van den Bos","year":"2016","journal-title":"Eur Radiol"},{"key":"R8-20260702","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1148\/radiol.2020192190","article-title":"High-voltage electrical pulses in oncology: irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy","volume":"295","author":"Geboers","year":"2020","journal-title":"Radiology"},{"key":"R9-20260702","doi-asserted-by":"crossref","first-page":"e009794","DOI":"10.1136\/jitc-2024-009794","article-title":"Irreversible electroporation synergizes with oncolytic virus enhances the infiltration of cytotoxic T lymphocytes in the tumor immune microenvironment: a leap from focal therapy to immunotherapy for prostate cancer","volume":"13","author":"Xia","year":"2025","journal-title":"J Immunother Cancer"},{"key":"R10-20260702","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.eururo.2025.06.003","article-title":"Irreversible electroporation for prostate tissue ablation in patients with intermediate-risk prostate cancer: results from the PRESERVE trial","volume":"89","author":"George","year":"2026","journal-title":"Eur Urol"},{"key":"R11-20260702","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamasurg.2022.2230","article-title":"Extended focal ablation of localized prostate cancer with high-frequency irreversible electroporation: a nonrandomized controlled trial","volume":"157","author":"Wang","year":"2022","journal-title":"JAMA Surg"},{"key":"R12-20260702","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12672-025-02025-0","article-title":"A preliminary follow-up study on irreversible electroporation therapy in older patients with prostate cancer","volume":"16","author":"Xia","year":"2025","journal-title":"Discov Oncol"},{"key":"R13-20260702","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.prnil.2025.09.004","article-title":"Irreversible electroporation for localized prostate cancer: risk-stratified oncologic outcomes and functional preservation","volume":"14","author":"Xia","year":"2026","journal-title":"Prostate Int"},{"key":"R14-20260702","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41391-022-00501-0","article-title":"Focal prostate cancer therapy in the era of multiparametric MRI: a review of options and outcomes","volume":"26","author":"Heard","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:47:25Z","timestamp":1786038445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006484","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"2025-12-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}